Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Biological Indicators Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Self-Contained Biological Indicator
  • 1.4.3 Biological Indicator Strip
• 1.5 Market by Application
  • 1.5.1 Global Biological Indicators Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Pharma Companies
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Biological Indicators Market Size
• 2.2 Biological Indicators Growth Trends by Regions
  • 2.2.1 Biological Indicators Market Size by Regions (2014-2025)
  • 2.2.2 Biological Indicators Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Biological Indicators Market Size by Manufacturers
  • 3.1.1 Global Biological Indicators Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Biological Indicators Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Biological Indicators Market Concentration Ratio (CR5 and HHI)
• 3.2 Biological Indicators Key Players Head office and Area Served
• 3.3 Key Players Biological Indicators Product/Solution/Service
• 3.4 Date of Enter into Biological Indicators Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Biological Indicators Market Size by Type (2014-2019)
• 4.2 Global Biological Indicators Market Size by Application (2014-2019)

5 United States

• 5.1 United States Biological Indicators Market Size (2014-2019)
• 5.2 Biological Indicators Key Players in United States
• 5.3 United States Biological Indicators Market Size by Type
• 5.4 United States Biological Indicators Market Size by Application

6 Europe

• 6.1 Europe Biological Indicators Market Size (2014-2019)
• 6.2 Biological Indicators Key Players in Europe
• 6.3 Europe Biological Indicators Market Size by Type
• 6.4 Europe Biological Indicators Market Size by Application

7 China

• 7.1 China Biological Indicators Market Size (2014-2019)
• 7.2 Biological Indicators Key Players in China
• 7.3 China Biological Indicators Market Size by Type
• 7.4 China Biological Indicators Market Size by Application

8 Japan

• 8.1 Japan Biological Indicators Market Size (2014-2019)
• 8.2 Biological Indicators Key Players in Japan
• 8.3 Japan Biological Indicators Market Size by Type
• 8.4 Japan Biological Indicators Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Biological Indicators Market Size (2014-2019)
• 9.2 Biological Indicators Key Players in Southeast Asia
• 9.3 Southeast Asia Biological Indicators Market Size by Type
• 9.4 Southeast Asia Biological Indicators Market Size by Application

10 India

• 10.1 India Biological Indicators Market Size (2014-2019)
• 10.2 Biological Indicators Key Players in India
• 10.3 India Biological Indicators Market Size by Type
• 10.4 India Biological Indicators Market Size by Application

11 Central & South America

• 11.1 Central & South America Biological Indicators Market Size (2014-2019)
• 11.2 Biological Indicators Key Players in Central & South America
• 11.3 Central & South America Biological Indicators Market Size by Type
• 11.4 Central & South America Biological Indicators Market Size by Application

12 International Players Profiles

• 12.1 3M
  • 12.1.1 3M Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Biological Indicators Introduction
  • 12.1.4 3M Revenue in Biological Indicators Business (2014-2019)
  • 12.1.5 3M Recent Development
• 12.2 Getinge Group
  • 12.2.1 Getinge Group Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Biological Indicators Introduction
  • 12.2.4 Getinge Group Revenue in Biological Indicators Business (2014-2019)
  • 12.2.5 Getinge Group Recent Development
• 12.3 Cantel Medical
  • 12.3.1 Cantel Medical Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Biological Indicators Introduction
  • 12.3.4 Cantel Medical Revenue in Biological Indicators Business (2014-2019)
  • 12.3.5 Cantel Medical Recent Development
• 12.4 Mesa Laboratories
  • 12.4.1 Mesa Laboratories Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Biological Indicators Introduction
  • 12.4.4 Mesa Laboratories Revenue in Biological Indicators Business (2014-2019)
  • 12.4.5 Mesa Laboratories Recent Development
• 12.5 Steris
  • 12.5.1 Steris Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Biological Indicators Introduction
  • 12.5.4 Steris Revenue in Biological Indicators Business (2014-2019)
  • 12.5.5 Steris Recent Development
• 12.6 Fuze Medical
  • 12.6.1 Fuze Medical Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Biological Indicators Introduction
  • 12.6.4 Fuze Medical Revenue in Biological Indicators Business (2014-2019)
  • 12.6.5 Fuze Medical Recent Development
• 12.7 Matachana
  • 12.7.1 Matachana Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Biological Indicators Introduction
  • 12.7.4 Matachana Revenue in Biological Indicators Business (2014-2019)
  • 12.7.5 Matachana Recent Development
• 12.8 Hu-Friedy
  • 12.8.1 Hu-Friedy Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Biological Indicators Introduction
  • 12.8.4 Hu-Friedy Revenue in Biological Indicators Business (2014-2019)
  • 12.8.5 Hu-Friedy Recent Development
• 12.9 Advanced Sterilization
  • 12.9.1 Advanced Sterilization Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Biological Indicators Introduction
  • 12.9.4 Advanced Sterilization Revenue in Biological Indicators Business (2014-2019)
  • 12.9.5 Advanced Sterilization Recent Development
• 12.10 Bag Health Care
  • 12.10.1 Bag Health Care Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Biological Indicators Introduction
  • 12.10.4 Bag Health Care Revenue in Biological Indicators Business (2014-2019)
  • 12.10.5 Bag Health Care Recent Development
• 12.11 Terragene
• 12.12 Andersen
• 12.13 GKE

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
North America region is the largest supplier of Biological Indicators, with a production market share nearly 54% in 2016. Europe is the second largest supplier of Biological Indicators, enjoying production market share nearly 33% in 2016.
North America is the largest consumption place, with a consumption market share nearly 45% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
In 2018, the global Biological Indicators market size was 290 million US$ and it is expected to reach 460 million US$ by the end of 2025, with a CAGR of 5.9% during 2019-2025.

This report focuses on the global Biological Indicators status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biological Indicators development in United States, Europe and China.

The key players covered in this study
3M
Getinge Group 
Cantel Medical
Mesa Laboratories
Steris
Fuze Medical
Matachana
Hu-Friedy
Advanced Sterilization
Bag Health Care
Terragene
Andersen
GKE

Market segment by Type, the product can be split into
Self-Contained Biological Indicator
Biological Indicator Strip

Market segment by Application, split into
Hospital
Pharma Companies
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biological Indicators status, future forecast, growth opportunity, key market and key players.
To present the Biological Indicators development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biological Indicators are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.